IITRI

Investigate.Collaborate.Communicate

ADVANCING SCIENCE TOGETHER

10 West 35th Street. Chicago, IL 60616

extend your your scientific team

IITRI collaborates with sponsors to establish a true partnership for the planning and execution of each study. Talk to us about your program today!

IITRI

Investigate.Collaborate.Communicate

ADVANCING SCIENCE TOGETHER

10 West 35th Street. Chicago, IL 60616

extend of your scientific team

IITRI collaborates with sponsors to establish a true partnership for the planning and execution of each study. Talk to us about your program today!

Our Experience is Exceptional

preclinical development services 

Over the past 40 years IITRI has established itself as a top-quality, full-service GLP-compliant preclinical contract research organization (CRO) that provides the complete IND-enabling preclinical safety and toxicology testing programs of a large CRO, with the personalized attention of a smaller organization.

We strive to establish a true partnership with our sponsors for the planning and execution of each study.

We offer accomplished study teams, with experienced and highly accessible PhD and DABT study directors having over 15 years’ tenure, and degreed technicians to conduct your study and provide information on study progress and early results throughout the program.  

IITRI specializes in GLP toxicology and safety studies, IND-enabling programs, infectious disease vaccine and therapeutic development, and inhalation toxicology programs for the biotech, pharmaceutical, and government sponsors. 

NEWS AND EVENTS

Service Spotlight: Exposure Atmosphere Characterization

Service Spotlight: Exposure Atmosphere Characterization

STARTING OFF ON THE RIGHT FOOT Our inhalation services include preliminary method development activities as the necessary first step for inhalation toxicology studies. The selection and characterization of the test atmosphere to be realistic and extensively measured...

New Partner Publications- Promising COVID-19 Studies

New Partner Publications- Promising COVID-19 Studies

  IITRI is proud to share the promising news from multiple sponsors of COVID-19 in vitro and in vivo studies. Links below to press releases and recent publications. Congrats all!   New IITRI Co-Author Publication: Scalable live-attenuated SARS-CoV-2 vaccine...

SARS-CoV-2 Variants of Concern Now Available

SARS-CoV-2 Variants of Concern Now Available

IITRI now has access to multiple SARS-CoV-2 variants. Currently available: B.1.1.7 (Alpha), B.1.351 (Beta), P.1 (Gamma). Available soon: B.1.617.1 (Kappa) and B.1.617.2 (Delta) These variants are available for use in our assays (immunostain and neutralization) as well...